Management of patients with myoclonus: available therapies and the need for an evidence-based approach

Lancet Neurol. 2010 Oct;9(10):1028-36. doi: 10.1016/S1474-4422(10)70193-9.

Abstract

Myoclonus is a hyperkinetic movement disorder characterised by quick and involuntary jerks. Therapy should focus on cure of an underlying disorder; however, symptomatic treatment is often needed when treatment of an underlying cause is impossible or ineffective. The appropriate treatment for a specific type of myoclonus is based on the classification of the anatomical origin of the myoclonus: cortical, subcortical, spinal, or peripheral. We outline criteria for classification and present an overview of the available therapeutic options for the different types of myoclonus. Because of a generally low level of evidence, therapeutic options mainly rely on small observational studies and expert opinion. For an evidence-based approach in the future, randomised controlled trials of symptomatic therapies for myoclonus in homogeneous patient groups are needed.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Management
  • Evidence-Based Medicine / methods*
  • Evidence-Based Medicine / trends
  • Humans
  • Myoclonus / classification
  • Myoclonus / diagnosis*
  • Myoclonus / therapy*